Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention

American Heart Journal

Volumn 161, Issue 2, 2011, Pages 383-390

  Ko, Young Guk ^a   Suh, Jung Won ^c   Kim, Bo Hyun ^a   Lee, Chan Joo ^a   Kim, Jung Sun ^a   Choi, Donghoon ^a   Hong, Myeong Ki ^a,b   Seo, Myung Ki ^c   Youn, Tae Jin ^c   Chae, In Ho ^c   Choi, Dong Joo ^c   Jang, Yangsoo ^a,b  

^a Yonsei University Health System   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DEATH; FEMALE; FUNCTION TEST; GERMANY; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE ELECTRODE PLATELET AGGREGOMETRY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STROKE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME; VERIFYNOW ASSAY;

ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 79851485451     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.10.036     Document Type: Article

References (25)

1. Ben-Dor I., Kleiman N.S., and Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy Am J Cardiol 104 2009 227 233
2. Kereiakes D.J., and Gurbel P.A. Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention J Am Coll Cardiol Interv 1 2008 111 121 (Pubitemid 351506557)
3. Gurbel P.A., Becker R.C., and Mann K.G. Platelet function monitoring in patients with coronary artery disease J Am Coll Cardiol 50 2007 1822 1834 (Pubitemid 350007957)
4. Gremmel T., Steiner S., and Seidinger D. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation Thromb Haemost 101 2009 333 339
5. Patti G., Nusca A., and Mangiacapra F. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
6. Price M.J., Endemann S., and Gollapudi R.R. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000 (Pubitemid 351844676)
7. Sibbing D., Braun S., and Morath T. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol 53 2009 849 856
8. Thygesen K., Alpert J.S., and White H.D. On behalf of the Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
9. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
10. Mehta S.K., Frutkin A.D., and Lindsey J.B. National Cardiovascular Data Registry. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry Circ Cardiovasc Interv 2 2009 222 229
11. Michelson A.D. Platelet function testing in cardiovascular diseases Circulation 110 2004 489 493
12. Lordkipanidzé M., Pharand C., and Schampaert E. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Eur Heart J 28 2007 1702 1708 (Pubitemid 47227104)
13. Breet N.J., van Werkum J.W., and Bouman H.J. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
14. Chen W.H., Lee P.Y., and Ng W. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J Am Coll Cardiol 43 2004 1122 1126 (Pubitemid 38353000)
15. Snoep J.D., Hovens M.M., and Eikenboom J.C. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and metaanalysis Arch Intern Med 167 2007 1593 1599 (Pubitemid 47280339)
16. Krasopoulos G., Brister S.J., and Beattie W.S. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 2008 195 198 (Pubitemid 351212675)
17. Lev E.I., Patel R.T., and Maresh K.J. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention. The role of dual drug resistance J Am Coll Cardiol 47 2006 27 33 (Pubitemid 43005160)
18. Ivandic B.T., Sausemuth M., and Ibrahim H. Dual antiplatelet drug resistance is a risk factor for cardiovascular events after percutaneous coronary intervention Clin Chem 55 2009 1171 1176
19. Lee J.M., Park S., and Shin D.J. Relation of genetic polymorphisms in the cytochrome p450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans Am J Cardiol 104 2009 46 51
20. Kim I.S., Choi B.R., and Jeong Y.H. The CYP2C192 and CYP2C193 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome J Thromb Haemost 7 2009 897 899
21. Trenk D., Hochholzer W., and Fromm M.F. Cytochrome P450 2C19 681G>A polymorphism and high on clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug eluting or bare-metal stents J Am Coll Cardiol 51 2008 1925 1934 (Pubitemid 351636443)
22. Frere C., Cuisset T., and Morange P.E. Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome Am J Cardiol 101 2008 1088 1093
23. Kimura T., Morimoto T., and Nakagawa Y. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 2009 987 995
24. Park D.W., Yun S.C., and Lee J.Y. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation Circulation 120 2009 1987 1995
25. Jeong Y.H., Kim I.S., and Choi B.R. The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay Eur Heart J 29 2008 2186 2187